Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Oral Progesterone in Transgender Women
NCT06807580Phase 2Recruiting
- Sponsor
- Emory University
- Start
- May 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in gender dysphoria (GD), sponsored by Emory University. Started May 2025; status: recruiting.
02
Drugs
progesterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT06807580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06807580.